Health & Her

Health & Her operates as a specialized digital health company focusing on the female hormonal health market, particularly targeting perimenopause and menopause. The company was established in 2019 by co-founders Kate Bache, who serves as CEO, and Gervase Fay, the Commercial Director, with their e-commerce platform launching in March of the same year. Bache, a qualified chemist, brings over 15 years of marketing and commercialization experience from the pharmaceutical and consumer health sectors. Fay contributes a decade of experience from roles at major companies like Tesco and Superdrug. Their shared vision was to create a supportive, personalized platform to help women navigate the complexities of hormonal changes.

The business model is centered around a direct-to-consumer and retail approach, offering a holistic ecosystem of products and services. Revenue is generated through the sale of its proprietary line of supplements, which are formulated based on research involving tens of thousands of women. These products are sold online via its website, on Amazon, and through major UK retailers like Boots, Holland & Barrett, and Superdrug. The company has a significant international presence, exporting to Ireland, Germany, China, and the US, where it has secured listings with retailers like Vitamin Shoppe.

The core offering includes a range of multi-nutrient supplements tailored for different stages of hormonal change, such as perimenopause, menopause, and post-menopause, as well as for women taking HRT or hormonal contraception. A key differentiator is the integration of its products with a free educational app. The Health & Her app allows users to track symptoms, identify triggers, access expert-led content, and receive personalized recommendations and exercises based on techniques like Cognitive Behavioural Therapy (CBT). This combination of physical products and digital support creates a comprehensive self-care hub. The company also provides access to a specialist online clinic for consultations with menopause specialist GPs. In October 2024, Venture Life Group announced the acquisition of Health & Her for an initial cash consideration of £7.5 million.

Keywords: femtech, women's health, menopause support, perimenopause, hormonal health, supplements, digital health, e-commerce, health and wellness, Kate Bache, Gervase Fay, symptom tracker, menopause app, female-founded, direct-to-consumer, health supplements, holistic health, self-care, post-menopause, Venture Life Group